Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: Substantial health and economic burden of COVID-19 during the year after acute illness among US adults not at high risk of severe COVID-19

  

Disposition during acute COVID-19 illness

Characteristic

All patients

(N = 3792)

No hospitalization

(n = 3546)

Hospitalization without ICU admission

(n = 164)

ICU admission

(n = 82)

Sex, n (%)

 Female

1648 (43.5)

1571 (44.3)

56 (34.1)

21 (25.6)

 Male

2144 (56.5)

1975 (55.7)

108 (65.9)

61 (74.4)

Age, years

 Mean ± SD

40.4 ± 12.2

39.9 ± 12.2

46.4 ± 11.8

48.0 ± 10.3

 Median (Q1; Q3)

40 (31; 50)

39 (30; 50)

47 (36.5; 56)

50.5 (41; 56)

Age group, years, n (%)

 18–29

859 (22.7)

838 (23.6)

15 (9.1)

6 (7.3)

 30–49

1900 (50.1)

1791 (50.5)

78 (47.6)

31 (37.8)

 50–64

1033 (27.2)

917 (25.9)

71 (43.3)

45 (54.9)

Race or ethnicity, n (%)

 White

1670 (44.0)

1599 (45.1)

49 (29.9)

22 (26.8)

 Black

397 (10.5)

359 (10.1)

21 (12.8)

17 (20.7)

 Hispanic

1078 (28.4)

984 (27.7)

66 (40.2)

28 (34.1)

 Asian

229 (6.0)

215 (6.1)

10 (6.1)

4 (4.9)

 Unknown

418 (11.0)

389 (11.0)

18 (11.0)

11 (13.4)

Geographic division, n (%)

 New England

236 (6.2)

227 (6.4)

7 (4.3)

2 (2.4)

 Mid-Atlantic

764 (20.1)

730 (20.6)

27 (16.5)

7 (8.5)

 East North Central

729 (19.2)

670 (18.9)

39 (23.8)

20 (24.4)

 West North Central

402 (10.6)

374 (10.5)

20 (12.2)

8 (9.8)

 South Atlantic

664 (17.5)

617 (17.4)

33 (20.1)

14 (17.1)

 East South Central

93 (2.5)

87 (2.5)

4 (2.4)

2 (2.4)

 West South Central

330 (8.7)

305 (8.6)

14 (8.5)

11 (13.4)

 Mountain

295 (7.8)

285 (8.0)

5 (3.0)

5 (6.1)

 Pacific

252 (6.7)

236 (6.7)

10 (6.1)

6 (7.3)

Insurance, n (%)

 Commercial

3756 (99.1)

3523 (99.4)

155 (94.5)

78 (95.1)

 Medicare

36 (0.9)

23 (0.6)

9 (5.5)

4 (4.9)

Care setting of COVID-19 diagnosis, n (%)

 Inpatient

181 (4.8)

0 (0.0)

128 (78.0)

53 (64.6)

 Outpatient

3611 (95.2)

3546 (100)

36 (22.0)

29 (35.4)

Disposition during acute COVID-19 illness, n (%)

 No hospitalization

3546 (93.5)

   

 Hospitalization without ICU admission

164 (4.3)

   

 ICU admission

82 (2.2)

   

COVID-19 inpatient stay that overlaps acute and post-acute phases (> 30 days), n (%)

9 (0.2)

0 (0.0)

2 (1.2)

7 (8.5)

  1. ICU intensive care unit, Q1 quartile 1, Q3 quartile 3